相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With the Risk of Hospitalization and Death in Hypertensive Patients With COVID-19
Rohan Khera et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)
Assessment of signal quality measured with a smart 12-lead ECG acquisition T-shirt
David Fouassier et al.
ANNALS OF NONINVASIVE ELECTROCARDIOLOGY (2020)
Will Artificial Intelligence for Drug Discovery Impact Clinical Pharmacology?
Alex Zhavoronkov et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
Richard S. Finn et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Deep learning for prediction of colorectal cancer outcome: a discovery and validation study
Ole-Johan Skrede et al.
LANCET (2020)
Improved protein structure prediction using potentials from deep learning
Andrew W. Senior et al.
NATURE (2020)
Biopharma dealmaking in 2019
Amanda Micklus et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
From single-arm studies to externally controlled studies. Methodological considerations and guidelines
Michel Cucherat et al.
THERAPIE (2020)
Comparison of Cardiovascular and Safety Outcomes of Chlorthalidone vs Hydrochlorothiazide to Treat Hypertension
George Hripcsak et al.
JAMA INTERNAL MEDICINE (2020)
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 A Randomized Trial
Caleb P. Skipper et al.
ANNALS OF INTERNAL MEDICINE (2020)
The Evolution of Master Protocol Clinical Trial Designs: A Systematic Literature Review
Elias Laurin Meyer et al.
CLINICAL THERAPEUTICS (2020)
Pooling Data From Individual Clinical Trials in the COVID-19 Era
Eva Petkova et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
David R. Boulware et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Digitizing clinical trials
O. T. Inan et al.
NPJ DIGITAL MEDICINE (2020)
An Alzheimer Disease Challenge Model: 24-Hour Sleep Deprivation in Healthy Volunteers, Impact on Working Memory, and Reversal Effect of Pharmacological Intervention A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
Anna Chan Kwong et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2020)
New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology
Perrine Janiaud et al.
CANCER TREATMENT REVIEWS (2019)
Archetype Analysis Identifies Distinct Profiles in Renal Transplant Recipients with Transplant Glomerulopathy Associated with Allograft Survival
Olivier Aubert et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Unbiased data analytic strategies to improve biomarker discovery in precision medicine
Saifur R. Khan et al.
DRUG DISCOVERY TODAY (2019)
New Guidelines for Statistical Reporting in the Journal
David Harrington et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Sharing of clinical trial data and results reporting practices among large pharmaceutical companies: cross sectional descriptive study and pilot of a tool to improve company practices
Jennifer Miller et al.
BMJ-British Medical Journal (2019)
Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study
Georgina Long et al.
LANCET ONCOLOGY (2019)
Artificial Intelligence for Drug Toxicity and Safety
Anna O. Basile et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Prospective cohort study of early biosignatures of response to lithium in bipolar-I-disorders: overview of the H2020-funded R-LiNK initiative
Jan Scott et al.
INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS (2019)
Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation
Marco V. Perez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Improving the odds of drug development success through human genomics: modelling study
Aroon D. Hingorani et al.
SCIENTIFIC REPORTS (2019)
The Innovative Medicines Initiative-10 Years of Public-Private Collaboration
Hugh Laverty et al.
FRONTIERS IN MEDICINE (2019)
Biomarker-guided trials: Challenges in practice
M. Antoniou et al.
CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS (2019)
Machine Learning Algorithm Predicts Cardiac Resynchronization Therapy Outcomes Lessons From the COMPANION Trial
Matthew M. Kalscheur et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2018)
Data sharing platforms for de-identified data from human clinical trials
Vojtech Huser et al.
CLINICAL TRIALS (2018)
Pre-Clinical Testing of Therapies for Traumatic Brain Injury
Douglas S. DeWitt et al.
JOURNAL OF NEUROTRAUMA (2018)
Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial
Thomas Powles et al.
LANCET (2018)
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2018)
Clinical Trial Participants' Views of the Risks and Benefits of Data Sharing
Michelle M. Mello et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Patient consent to publication and data sharing in industry and NIH-funded clinical trials
O'Mareen Spence et al.
TRIALS (2018)
Data sharing and reanalysis of randomized controlled trials in leading biomedical journals with a full data sharing policy: survey of studies published in The BMJ and PLOS Medicine
Florian Naudet et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Data sharing and reanalysis of randomized controlled trials in leading biomedical journals with a full data sharing policy: survey of studies published in The BMJ and PLOS Medicine
Florian Naudet et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Availability and Use of Shared Data From Cardiometabolic Clinical Trials
Muthiah Vaduganathan et al.
CIRCULATION (2018)
Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037)
Tara C. Mitchell et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
On-Demand Sildenafil as a Treatment for Raynaud Phenomenon A Series of n-of-1 Trials
Matthieu Roustit et al.
ANNALS OF INTERNAL MEDICINE (2018)
Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects
David M. Kent et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Targeting CYP51 for drug design by the contributions of molecular modeling
Vitor W. Rabelo et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2017)
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
Arjun V. Balar et al.
LANCET (2017)
FDA Regulation of Prescription Drugs
Audrey L. Gassman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Data sharing statements for clinical trials
Darren B. Taichman et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Data sharing statements for clinical trials
Darren B. Taichman et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Practical implications of using real-world evidence (RWE) in comparative effectiveness research: learnings from IMI-GetReal
Amr Makady et al.
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2017)
Impact of Stroke Therapy Academic Industry Roundtable (STAIR) Guidelines on Peri-Anesthesia Care for Rat Models of Stroke: A Meta-Analysis Comparing the Years 2005 and 2015
Aurelie Thomas et al.
PLOS ONE (2017)
The Role of Public-Private Partnerships in Catalyzing the Critical Path
Kimberly E. Maxfield et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2017)
Microdosing and Other Phase 0 Clinical Trials: Facilitating Translation in Drug Development
T. Burt et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2016)
Sharing of Data From Industry-Funded Registered Clinical Trials
Isabelle Boutron et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Data Sharing An Ethical and Scientific Imperative
Howard Bauchner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
N-of-1 trials to enhance patient outcomes: identifying effective therapies and reducing harms, one patient at a time
Sunita Vohra
JOURNAL OF CLINICAL EPIDEMIOLOGY (2016)
Innovation in the pharmaceutical industry: New estimates of R&D costs
Joseph A. DiMasi et al.
JOURNAL OF HEALTH ECONOMICS (2016)
Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic Data
Alexander Aliper et al.
MOLECULAR PHARMACEUTICS (2016)
Data Sharing and the Journal
Jeffrey M. Drazen
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Sharing Clinical Trial Data - A Proposal from the International Committee of Medical Journal Editors
Darren B. Taichman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Pragmatic Trials
Ian Ford et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
What usage and what hierarchical order for secondary endpoints?
Silvy Laporte et al.
THERAPIE (2016)
No improvement in the reporting of clinical trial subgroup effects in high-impact general medical journals
Nicole B. Gabler et al.
TRIALS (2016)
FAF-Drugs3: a web server for compound property calculation and chemical library design
David Lagorce et al.
NUCLEIC ACIDS RESEARCH (2015)
Unique in the shopping mall: On the reidentifiability of credit card metadata
Yves-Alexandre de Montjoye et al.
SCIENCE (2015)
The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting
K. Hemming et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
The PRECIS-2 tool: designing trials that are fit for purpose
Kirsty Loudon et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting
K. Hemming et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
The PRECIS-2 tool: designing trials that are fit for purpose
Kirsty Loudon et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Experimental design and reporting standards for improving the internal validity of pre-clinical studies in the field of pain: Consensus of the IMI-Europain consortium
K. L. Knopp et al.
SCANDINAVIAN JOURNAL OF PAIN (2015)
Reanalyses of Randomized Clinical Trial Data
Shanil Ebrahim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Development of a Database for Translational Spinal Cord Injury Research
Jessica L. Nielson et al.
JOURNAL OF NEUROTRAUMA (2014)
Comparison of Survival Outcomes Among Cancer Patients Treated In and Out of Clinical Trials
Joseph M. Unger et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Internet-based randomized controlled trials: a systematic review
Erin Mathieu et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2013)
Internet trials: participant experiences and perspectives
Erin Mathieu et al.
BMC MEDICAL RESEARCH METHODOLOGY (2012)
The Imperative to Share Clinical Study Reports: Recommendations from the Tamiflu Experience
Peter Doshi et al.
PLOS MEDICINE (2012)
Aggregating single patient (n-of-1) trials in populations where recruitment and retention was difficult: The case of palliative care
Jane Nikles et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Illustrating bias due to conditioning on a collider
Stephen R. Cole et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2010)
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Steven M. Paul et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Rethinking pragmatic randomised controlled trials: introducing the cohort multiple randomised controlled trial design
Clare Relton et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes
Linda E. Levesque et al.
BRITISH MEDICAL JOURNAL (2010)
Methodological Challenges in Online Trials
Elizabeth Murray et al.
JOURNAL OF MEDICAL INTERNET RESEARCH (2009)
Immortal time bias in pharmacoepidemiology
Samy Suissa
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Better outcomes for patients treated at hospitals that participate in clinical trials
Sumit R. Majumdar et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Reproducible research: Moving toward research the public can really trust
Christine Laine et al.
ANNALS OF INTERNAL MEDICINE (2007)
Drug development and the FDA's critical path initiative
R. L. Woosley et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Treating Individuals 1 - External validity of randomised controlled trials: To whom do the results of this trial apply?'
PM Rothwell
LANCET (2005)
Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations
L Kaiser et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
分享论文
